TOX3 and breast carcinoma: Using TaqMan SNP Genotyping Assays, we evaluated FGFR2 rs2981582, TNRC9 rs3803662, TNRC9 rs12443621, and LP1 rs3817198 polymorphisms in 487 subjects, including 105 breast cancer cases and 382 controls.